News
-
-
-
COMMUNIQUÉ DE PRESSE
Jaguar Health Secures an Additional $3 Million Payment from Future Pak for Mytesi and Canalevia-CA1
Jaguar Health, Inc. receives $16M non-dilutive capital from U.S. license agreement with Future Pak for crofelemer drugs. Strategy focuses on rare-disease intestinal failure indications -
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Unusual Machines to Participate in Two March Investor Conferences
Unusual Machines announces participation in investor conferences during March 2026 in NY and CA. Their executive team will meet with institutional investors. The company specializes in NDAA-compliant drone components and aims to dominate the U.S. drone parts market